Enhancing Coordination, Integration and Dissemination of Evidence to Combat HIV/AIDS, TB, and Sexually Transmitted Infections (STI) in the Republic of Zambia under the President’s Emergency Plan for AIDS Relief (PEPFAR) | CDC RFA GH15 160202CONT16

Opportunity Information: Apply for CDC RFA GH15 160202CONT16

This grant opportunity is a continuation funding announcement from the U.S. Centers for Disease Control and Prevention (CDC) under PEPFAR, focused on Zambia and centered on strengthening the way evidence is coordinated, integrated, and shared to improve the national response to HIV/AIDS, tuberculosis (TB), and sexually transmitted infections (STIs). The core idea is not simply to fund service delivery in isolation, but to support systems and processes that help decision-makers and implementers work from the same evidence base, align efforts across programs, and disseminate findings in ways that lead to better planning, better targeting of resources, and stronger public health impact.

The opportunity is issued as a Cooperative Agreement, which usually means CDC expects substantial involvement in the work beyond standard grant oversight. In practice, that kind of arrangement often involves close technical collaboration, shared planning, joint review of deliverables, and ongoing coordination to ensure that activities remain aligned with PEPFAR goals and CDC priorities. The funding activity category is Health, and the CFDA number is 93.067, which is commonly associated with CDC global HIV-related cooperative agreement work.

A key constraint of this announcement is eligibility: it is specifically continuation funding intended only for organizations that were previously awarded under the earlier funding opportunity CDC-RFA-GH15-1602, which carries the same program title. In other words, this is not an open competition for new applicants; it is designed to extend or continue support for existing grantees that were already implementing the underlying project. The listing shows the opportunity category as Continuation, reinforcing that it is meant to maintain momentum and continuity of an existing body of work rather than start a brand-new project with new partners.

Programmatically, the title and description point to work that strengthens coordination and integration across the HIV, TB, and STI portfolio, and improves dissemination of evidence. That typically includes activities like supporting national or subnational coordination structures, improving linkages among disease programs that historically can operate in silos, and ensuring that surveillance, monitoring and evaluation outputs, operational research, program evaluations, and routine reporting are translated into usable guidance for planners and implementers. The emphasis on "dissemination of evidence" suggests an expectation that data and findings should not remain in reports or databases, but be actively packaged and shared through briefs, technical updates, stakeholder forums, and other channels that help drive policy and implementation decisions.

The geographic focus is the Republic of Zambia, and the initiative sits under the broader PEPFAR framework, which generally prioritizes measurable impact in HIV prevention, care, and treatment while also supporting related disease areas like TB (given the strong HIV/TB overlap) and STIs (given their role in transmission dynamics and reproductive health outcomes). The integration language implies that the work should encourage coordinated planning and complementary interventions, for example aligning HIV and TB activities, improving cross-referrals, harmonizing guidelines, and using shared data systems or shared analytic products where appropriate.

Administratively, the source fields indicate the funding opportunity number CDC RFA GH15 160202CONT16, with a creation date of 2015-09-16 and an original closing date of 2015-10-23. The award ceiling is listed as 0 in the record, which commonly indicates that a specific ceiling is not provided in the public summary or is handled through internal continuation award determinations rather than a competitive cap. The record also shows "ExpectedAwards:" without a number, which is consistent with continuation announcements where the number of awards is effectively predetermined by the existing cohort of prior recipients.

In plain terms, this announcement is best read as CDC/PEPFAR continuing to fund the same Zambia-based partners from the earlier award to keep advancing a coordinated, evidence-driven national response to HIV, TB, and STIs. The defining features are continuity (restricted to prior grantees), a collaborative cooperative-agreement structure, and a program focus on strengthening coordination and integration while making sure evidence is actively synthesized and disseminated so it can be used to improve policies, programs, and overall public health outcomes.

• The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Enhancing Coordination, Integration and Dissemination of Evidence to Combat HIV/AIDS, TB, and Sexually Transmitted Infections (STI) in the Republic of Zambia under the President’s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on 2015-09-16.
• Applicants must submit their applications by 2015-10-23. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: Others.

Apply for CDC RFA GH15 160202CONT16

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: